The National Stock Exchange of India Limited (NSE) has confirmed that aster dm healthcare will change its corporate name to Aster DM Quality Care Limited effective July 28, 2026. This renaming action reflects a strategic shift in the company’s branding identity while maintaining continuity in its market presence. The change applies to the entity currently listed under the name Aster DM Healthcare Limited.

Change in Corporate Name

The NSE issued Circular Ref. No. 1200/2026 on July 22, 2026, notifying all exchange members of the impending name change. The circular states that the new name will be effective w.e.f. July 28, 2026. This procedural update ensures that all trading, settlement, and corporate actions are aligned with the new nomenclature from the specified date.

Trading Symbol Continuity

Despite the change in the corporate name, the trading symbol for the company remains unchanged. This ensures that existing investors and traders do not need to adjust their portfolios or trading systems regarding the ticker identifier. The details of the change are outlined below:

The existing symbol "ASTERDM" will continue to be used for trading purposes. The new name, Aster DM Quality Care Limited, will replace the previous name in all official records and disclosures starting from the effective date.

Regulatory Compliance

The name change is subject to regulatory approvals and compliance with the listing regulations of the NSE. The circular serves as an official notification to the market participants, ensuring transparency and timely dissemination of information. Investors are advised to note the effective date for any future correspondence or documentation related to the company.

What the Numbers Show

While this announcement is primarily administrative, it signals a potential rebranding effort by the management. The retention of the trading symbol suggests that the core business operations and market perception remain stable during this transition. The effective date of July 28, 2026, provides a clear timeline for stakeholders to update their records.

Aster DM Healthcare Ltd disclosed that the shareholding of its promoter and promoter group has diluted to 24.01% from 40.39% following the allotment of equity shares to shareholders of Quality Care India Limited (QCIL). The allotment was executed on July 13, 2026, pursuant to a Scheme of Amalgamation sanctioned by the National Company Law Tribunal, Hyderabad Bench. This restructuring increased the total equity share capital of Aster DM Quality Care Limited, formerly known as Aster DM Healthcare Limited, significantly altering the ownership structure.

The transaction involved an exchange ratio of 977 equity shares of Aster DM Quality Care Limited for every 1,000 equity shares held in QCIL. While the total number of shares held by the Aster Promoters remained constant at 20,92,83,923, the expansion of the company's equity base resulted in the dilution of their stake. The total equity share capital post-allotment rose to 87,16,72,439 shares from 51,81,21,029 shares prior to the transaction.

Shareholding Details

The disclosure was submitted in accordance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, due to a change in promoter shareholding exceeding 2%. The acquirer, BCP Asia II Topco IV Pte. Ltd., which is part of the Persons Acting in Concert (PAC), was also classified under the Promoter group in previous disclosures.

The filing confirmed that there are no shares held under encumbrance, nor are there any warrants or convertible securities involved in this transaction. The disclosure was signed by Dr. Azad Moopen, Executive Chairman & Promoter, on behalf of the Aster Promoters on July 14, 2026.